Matei D - Search Results

1

Epigenetic Attire in Ovarian Cancer: The Emperor's New Clothes.

Matei D, Nephew KP. Matei D, et al. Cancer Res. 2020 Sep 15;80(18):3775-3785. doi: 10.1158/0008-5472.CAN-19-3837. Epub 2020 May 7. Cancer Res. 2020. PMID: 32381656 Free PMC article. Review.

2

Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer.

Chan MW, Wei SH, Wen P, Wang Z, Matei DE, Liu JC, Liyanarachchi S, Brown R, Nephew KP, Yan PS, Huang TH. Chan MW, et al. Clin Cancer Res. 2005 Oct 15;11(20):7376-83. doi: 10.1158/1078-0432.CCR-05-1100. Clin Cancer Res. 2005. PMID: 16243810

3

PDGF BB induces VEGF secretion in ovarian cancer.

Matei D, Kelich S, Cao L, Menning N, Emerson RE, Rao J, Jeng MH, Sledge GW. Matei D, et al. Cancer Biol Ther. 2007 Dec;6(12):1951-9. doi: 10.4161/cbt.6.12.4976. Epub 2007 Sep 1. Cancer Biol Ther. 2007. PMID: 18075302 Free article.

4

Identification and characterization of ovarian cancer-initiating cells from primary human tumors.

Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP. Zhang S, et al. Among authors: matei d. Cancer Res. 2008 Jun 1;68(11):4311-20. doi: 10.1158/0008-5472.CAN-08-0364. Cancer Res. 2008. PMID: 18519691 Free PMC article.

5

Minireview: epigenetic changes in ovarian cancer.

Balch C, Fang F, Matei DE, Huang TH, Nephew KP. Balch C, et al. Endocrinology. 2009 Sep;150(9):4003-11. doi: 10.1210/en.2009-0404. Epub 2009 Jul 2. Endocrinology. 2009. PMID: 19574400 Free PMC article. Review.

6

Epigenetic therapies for chemoresensitization of epithelial ovarian cancer.

Matei DE, Nephew KP. Matei DE, et al. Gynecol Oncol. 2010 Feb;116(2):195-201. doi: 10.1016/j.ygyno.2009.09.043. Epub 2009 Oct 24. Gynecol Oncol. 2010. PMID: 19854495 Free PMC article. Review.

7

Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase.

Shao M, Cao L, Shen C, Satpathy M, Chelladurai B, Bigsby RM, Nakshatri H, Matei D. Shao M, et al. Among authors: matei d. Cancer Res. 2009 Dec 15;69(24):9192-201. doi: 10.1158/0008-5472.CAN-09-1257. Cancer Res. 2009. PMID: 19951993

8

A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer.

Fang F, Balch C, Schilder J, Breen T, Zhang S, Shen C, Li L, Kulesavage C, Snyder AJ, Nephew KP, Matei DE. Fang F, et al. Cancer. 2010 Sep 1;116(17):4043-53. doi: 10.1002/cncr.25204. Cancer. 2010. PMID: 20564122 Free PMC article. Clinical Trial.

9

Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer: a meta-analysis.

Hess LM, Rong N, Monahan PO, Gupta P, Thomaskutty C, Matei D. Hess LM, et al. Among authors: matei d. Cancer. 2010 Nov 15;116(22):5251-60. doi: 10.1002/cncr.25487. Cancer. 2010. PMID: 20665885 Free PMC article.

10

Blockade of FGF signaling: therapeutic promise for ovarian cancer.

Ivan M, Matei D. Ivan M, et al. Among authors: matei d. Cancer Biol Ther. 2010 Sep 1;10(5):505-8. doi: 10.4161/cbt.10.5.13023. Epub 2010 Sep 15. Cancer Biol Ther. 2010. PMID: 20686363 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters